(Q36964723)

17 August 2017

1 reference

title

Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis (English)

1 reference

17 August 2017

1 reference

E Michael Lewiecki

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Expert Opinion on Investigational Drugs

17 August 2017

published in

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

page(s)

1663-1672

1 reference

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

The crippling consequences of fractures and their impact on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

SERMs: evolutionary chemistry, revolutionary biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Bazedoxifene: a third-generation selective estrogen receptor modulator for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Transient disturbance in physeal morphology is associated with long-term effects of nitrogen-containing bisphosphonates in growing rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

The effect of estrogens and antiestrogens in a rat model for hot flush

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

Accretion of bone quantity and quality in the developing mouse skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1663

10.1517/13543784.16.10.1663

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference